Prevalence and genetic basis of Mycobacterium tuberculosis resistance to pretomanid in China
Abstract Background Pretomanid is a key component of new regimens for the treatment of drug-resistant tuberculosis (TB) which are being rolled out globally. However, there is limited information on the prevalence of pre-existing resistance to the drug. Methods To investigate pretomanid resistance ra...
Saved in:
Main Authors: | Bing Zhao (Author), Huiwen Zheng (Author), Juliano Timm (Author), Zexuan Song (Author), Shaojun Pei (Author), Ruida Xing (Author), Yajie Guo (Author), Ling Ma (Author), Feina Li (Author), Qing Li (Author), Yan Li (Author), Lin Huang (Author), Chong Teng (Author), Ni Wang (Author), Aastha Gupta (Author), Sandeep Juneja (Author), Fei Huang (Author), Yanlin Zhao (Author), Xichao Ou (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Baseline and acquired resistance to bedaquiline, linezolid and pretomanid, and impact on treatment outcomes in four tuberculosis clinical trials containing pretomanid.
by: Juliano Timm, et al.
Published: (2023) -
Pretomanid for tuberculosis treatment: an update for clinical purposes
by: Sara Occhineri, et al.
Published: (2022) -
Investigation of bedaquiline resistance and genetic mutations in multi-drug resistant Mycobacterium tuberculosis clinical isolates in Chongqing, China
by: Yan Hu, et al.
Published: (2023) -
Pretomanid dose selection for pulmonary tuberculosis: An application of multi‐objective optimization to dosage regimen design
by: Michael A. Lyons
Published: (2021) -
High diversity of clinical Mycobacterium intracellulare in China revealed by whole genome sequencing
by: Zexuan Song, et al.
Published: (2022)